Drugs / m-IPV2 HD
last change May 2014 re-read 2 minutes ago

m-IPV2 HD

Vaccine

Developed for
poliomyelitis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01997632 Comparator Nov 2013 → May 2014 poliomyelitis University Hospital, Ghent Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as m-IPV2 HD ClinicalTrials.gov intervention name — accepted as the source's own label NCT01997632
Modality Vaccine “m-IPV2 HD (vaccine that only contains polio serotype 2 in high dose)” NCT01997632
Route Intramuscular “m-IPV2 HD) Given Intramuscularly Compared” NCT01997632